Summary
48 / 100 · Bulios Score
What speaks for it
- It has raised its dividend 11 years in a row and pays out only 16% of profit.
- It bought back its own shares for $19.1M in the last fiscal year, 3.2% of its market value.
What to watch
- Revenue fell by 13% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
- Out of every 100 USD of revenue, only 3.0 USD is left as net profit.
- Operating profit covers the interest on its debt only 2.3 times.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 9.0 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 14% a year over 5 years. Over the last 3 years it fell by 13% a year. For the next fiscal year analysts expect revenue to grow by 0.9%. Earnings per share fell by 27% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 USD of revenue goes
- Cost of sales 81 USD
- Research and development 0.1 USD
- Sales and administration 14 USD
- Taxes and other 1.4 USD
- Net profit 3.0 USD
Net profit, industry median (Industrial - Distribution) 4.1 USD
Out of every 100 USD of revenue, 3.0 USD is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 4.2 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.83%
- Paid out of profit
- 16%
- Raised in a row
- 11 years
You receive $0.46 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 4
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.